First published in 2010, the EULAR recommendations for the management of RA, the most frequent inflammatory rheumatic disease ...

Greater understanding of the potential role played by B cells in autoimmune disease has spurred an interest in targeting B cells therapeutically. Greater understanding of the potential role played by ...

Understanding the type of arthritis, its causes, and management options is the first step toward living well with the ...

Advances in biotechnology, a greater understanding of the immunopathogenesis of rheumatoid arthritis (RA) and a desire for more effective therapeutics have led to the development of a class of ...

The treat-to-target approach represented a stepped-up model for chronic disease management that only became possible when the available therapies showed the potential for disease remission. The ...

First published in 2010, the EULAR recommendations for the management of RA, the most frequent inflammatory rheumatic disease ...

Treatments and outcomes for rheumatoid arthritis (RA) have made major advances in the last decade. Earlier diagnoses, better treatment strategies, and improvements in disease modifying anti-rheumatic ...

Novel “RA Response Calculator” Uses AI and Real Patient Data to Help Doctors Better Tailor Treatment Plans At the European Congress of Rheumatology (EULAR) 2025, Scipher Medicine, the company behind ...

Peripheral neuropathy can develop as a complication of rheumatoid arthritis (RA). You may find similar treatments for both, but your doctor is best equipped to determine what medications may work for ...

Hydroxychloroquine, initially a malaria treatment, may help with autoimmune conditions like RA by modulating the immune system and reducing inflammation. RA symptoms may improve within 2 months of ...